These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 7616754)

  • 21. Clinical development plan: phenethyl isothiocyanate.
    J Cell Biochem Suppl; 1996; 26():149-57. PubMed ID: 9154175
    [No Abstract]   [Full Text] [Related]  

  • 22. Re: Design and endpoints of clinical trials in hepatocellular carcinoma.
    Di Maio M; Daniele B; Gallo C; Perrone F
    J Natl Cancer Inst; 2008 Nov; 100(21):1557; author reply 1557-8. PubMed ID: 18957679
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical development plan: DHEA analog 8354.
    Kelloff GJ; Crowell JA; Boone CW; Steele VE; Lubet RA; Greenwald P; Alberts DS; Covey JM; Doody LA; Knapp GG
    J Cell Biochem Suppl; 1994; 20():141-6. PubMed ID: 7616739
    [No Abstract]   [Full Text] [Related]  

  • 24. Standardization, more funds on horizon for clinical trials.
    McNeil C
    J Natl Cancer Inst; 2005 Apr; 97(8):555-7. PubMed ID: 15840874
    [No Abstract]   [Full Text] [Related]  

  • 25. New paradigm in dose-finding trials: patient-specific dosing and beyond phase I.
    Rogatko A; Babb JS; Tighiouart M; Khuri FR; Hudes G
    Clin Cancer Res; 2005 Aug; 11(15):5342-6. PubMed ID: 16061846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical development plan: calcium.
    Kelloff GJ; Crowell JA; Boone CW; Steele VE; Lubet RA; Greenwald P; Alberts DS; Covey JM; Doody LA; Knapp GG
    J Cell Biochem Suppl; 1994; 20():86-109. PubMed ID: 7616756
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical development plan: ursodiol.
    J Cell Biochem Suppl; 1996; 26():258-68. PubMed ID: 9154182
    [No Abstract]   [Full Text] [Related]  

  • 28. A 25-year review of sequential methodology in clinical studies.
    Todd S
    Stat Med; 2007 Jan; 26(2):237-52. PubMed ID: 17139691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The scope and requirements related to preclinical and clinical studies of a new medicinal product, including biotechnological and biosimilar products.
    Brodniewicz-Proba T
    Acta Pol Pharm; 2008; 65(6):641-5. PubMed ID: 19172845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic vaccine trails in Thailand.
    Churdboonchart V
    J HIV Ther; 2004 Sep; 9(3):57-9. PubMed ID: 15534562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A combination phase I/II study--dose escalation plan].
    Yamamoto N
    Gan To Kagaku Ryoho; 2000 Dec; 27(14):2267-74. PubMed ID: 11142175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Methodological approaches of clinical studies with targeted therapies].
    Penel N; Saleron J; Lansiaux A; Clisant S; Adenis A; Fournier C; Duhamel A; Bonneterre J
    Bull Cancer; 2008 Feb; 95(2):185-90. PubMed ID: 18304903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical development plan: genistein.
    J Cell Biochem Suppl; 1996; 26():114-26. PubMed ID: 9154172
    [No Abstract]   [Full Text] [Related]  

  • 34. Phase I clinical trials: overcoming barriers.
    Bates SE
    Clin Cancer Res; 2010 Mar; 16(6):1709. PubMed ID: 20215552
    [No Abstract]   [Full Text] [Related]  

  • 35. How does the FDA's drug approval process work?
    Miller DJ
    ONS Connect; 2014 Jun; 29(2):43. PubMed ID: 24961046
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical development plan: curcumin.
    J Cell Biochem Suppl; 1996; 26():72-85. PubMed ID: 9154169
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical development plan: dehydroepiandrosterone (DHEA).
    J Cell Biochem Suppl; 1996; 26():86-99. PubMed ID: 9154170
    [No Abstract]   [Full Text] [Related]  

  • 38. Oncology's first Phase 0 trial.
    Rowan K
    J Natl Cancer Inst; 2009 Jul; 101(14):978-9. PubMed ID: 19584322
    [No Abstract]   [Full Text] [Related]  

  • 39. Selecting promising ALS therapies in clinical trials.
    Glass JD; Benatar M; Polak M
    Neurology; 2007 May; 68(18):1545-6; author reply 1546. PubMed ID: 17470765
    [No Abstract]   [Full Text] [Related]  

  • 40. [Challenges and concerns in early-phase clinical trials].
    Gordin A; Scheinin H
    Duodecim; 1992; 108(11):1026-36. PubMed ID: 1366021
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.